Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $7.24 Billion |
|---|---|
| Enterprise Value | $-140,953,714,340.00 |
| Annual dividend | $0.14 |
| Dividend yield | 3.24% |
| Earnings per Share | $52.73 |
| Beta | 0.14 |
| Outstanding Shares | 1,410,582,000 |
| P/E Ratio | 15.57 |
|---|---|
| PEG | -195.97 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 2.06 |
| Enterprise Value to EBIT | 9.37 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.13 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $153,040▼ 57.85% |
| Investors Holding | 4▼ 2.00% |
Ono Pharmaceutical Co., Ltd., along with its affiliated companies, is engaged in the global development, manufacturing, procurement, and sale of a diverse range of pharmaceutical products and diagnostic tools. Its diverse oncology portfo...